Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

New Credit Facility

2 Sep 2011 07:00

RNS Number : 5118N
Ferrexpo PLC
02 September 2011
 



2 September 2011

Ferrexpo plc

("Ferrexpo", the "Group" or the "Company")

 

New Credit Facility

 

Ferrexpo is pleased to announce that it has secured a new credit facility of US$420 million ("the credit facility"). The credit facility can be drawn at any time during the loan term which has a maturity of 5 years including amortization over 2 years.

 

The new credit facility carries a cost of 225bps above LIBOR on drawn amounts, and will initially remain undrawn.

 

ING Bank N.V., UniCredit Bank AG, and Société Générale Corporate and Investment Banking acted as Co-ordinating Mandated Lead Arrangers alongside 7 other prominent financial institutions:

 

·; UniCredit Bank Austria AG

·; West LB AG

·; ICBC London plc

·; ABN Amro Bank N.V.

·; Credit Suisse AG

·; J.P. Morgan Limited

·; Citibank N.A.

 

The Co-ordinating Mandated Lead Arrangers together with West LB and ICBC acted as book runners. UniCredit Bank AG acted as Documentation Co-ordinator, ING the Facility Agent, and ICBC as Credit Support Account Agent.

 

Chris Mawe, Chief Financial Officer of Ferrexpo said:

 

"This new credit facility is testimony to the strength of Ferrexpo's balance sheet and the quality of the business. The size and tenor of the facility complements the Group's recent US$500 million Eurobond issue and provides the necessary financial flexibility to continue to develop the Group's significant project pipeline."

 

For further information, please contact:

 

Ferrexpo:

Ingrid McMahon

+44 207 389 8304

Pelham Bell Pottinger

Charles Vivian

+44 207 861 3126

James Macfarlane

+44 207 861 3864

 

Notes to Editors:

 

Ferrexpo is a Swiss headquartered iron ore company with assets in Ukraine. It is principally involved in the production and export of high quality iron ore pellets, which are used in the manufacture of steel. Ferrexpo's resource base is one of the largest iron ore deposits in the world. Its current producing asset, FPM, produced approximately 10 million tonnes of iron ore pellets in 2010 making it the largest exporter of pellets in the CIS. The Company has a diversified customer base supplying steel mills in Austria, Serbia, Slovakia, Czech Republic, Germany and other European states, as well as in China, India, Japan, and other Asian countries. Ferrexpo is listed on the main market of the London Stock Exchange under the ticker FXPO. For further information, please visit www.ferrexpo.com 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUSVRAAAKRRR
Date   Source Headline
25th Feb 20227:00 amRNSOperational Update
24th Feb 20229:29 amRNSOperational Update
21st Feb 20227:00 amRNSNotice of Full Year Results
15th Feb 20227:00 amRNSAppointment of Chief Executive Officer
11th Feb 20227:00 amRNSChanges to Board Roles
31st Jan 202210:21 amRNSDirector/PDMR Shareholding
28th Jan 20227:00 amRNSNew Corporate Website
12th Jan 20227:00 amRNSProduction Report and Trading Update for 4Q 2021
30th Dec 20217:00 amRNSAppointment of Independent Non-executive Director
22nd Dec 20217:00 amRNSAnnouncement of Interim Dividend
16th Nov 202111:00 amRNSPresentation for Analyst Roundtable Meeting
16th Nov 20217:00 amRNSAnnouncement of Shareholder Returns Policy
11th Oct 20217:00 amRNSAnnouncement of Decarbonisation Targets
6th Oct 20217:00 amRNSProduction Report for 3Q 2021
21st Sep 20211:35 pmRNSDirector Declaration
17th Sep 202112:54 pmRNSResults of General Meeting
8th Sep 20217:00 amRNSPresentation to Institutional Investor Conference
31st Aug 20212:01 pmRNSDirector/PDMR Shareholding
25th Aug 20214:40 pmRNSHolding(s) in Company
25th Aug 20217:00 amRNSNotice of General Meeting
4th Aug 20217:01 amRNSPublication of Responsible Business Report
4th Aug 20217:00 amRNSInterim Results for six months ended 30 June 2021
19th Jul 20217:00 amRNSNotice of Interim Results
7th Jul 20217:01 amRNSAppointment of Group Chief Financial Officer
7th Jul 20217:00 amRNSProduction Report for 2Q 2021
5th Jul 20213:57 pmRNSDirector/PDMR Shareholding
1st Jul 20213:50 pmRNSHolding(s) in Company
30th Jun 20217:00 amRNSEarly Repayment of Debt Facility
28th Jun 20212:47 pmRNSHolding(s) in Company
25th Jun 20217:00 amRNSReport on Payments to Governments for 2020
23rd Jun 20215:17 pmRNSHolding(s) in Company
11th Jun 20213:32 pmRNSHolding(s) in Company
7th Jun 20214:54 pmRNSDirector Declaration
27th May 20213:00 pmRNSResults of Annual General Meeting
27th May 20217:00 amRNSAGM Presentation and Chair Address
6th May 202110:41 amRNSDirector/PDMR Shareholding
19th Apr 20213:20 pmRNSDirector/PDMR Shareholding
16th Apr 20217:00 amRNSNotice of AGM, Annual Report and Final Dividend
8th Apr 20217:00 amRNSProduction Report for 1Q 2021
17th Mar 20217:00 amRNS2020 Full Year Financial Results
1st Mar 20217:00 amRNSAppointment of Independent Non-executive Director
23rd Feb 20217:00 amRNSNotice of Full Year Results
29th Jan 20213:51 pmRNSDirector/PDMR Shareholding
13th Jan 20212:12 pmRNSDirector/PDMR Shareholding
12th Jan 20217:01 amRNSAppointment of Financial Adviser and Broker
12th Jan 20217:00 amRNSTrading Update and Production Report for 4Q 2020
5th Jan 20217:00 amRNSSpecial Interim Dividend Announcement
3rd Dec 20207:00 amRNSFerrexpo Investor Presentation
30th Nov 20207:00 amRNSKyiv Court Cancels Ferrexpo AG Share Restriction
9th Oct 20202:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.